HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immediate and delayed cord clamping in infants born between 24 and 32 weeks: a pilot randomized controlled trial.

AbstractOBJECTIVE:
This pilot study's aim was to establish feasibility of a protocol for delayed cord clamping (DCC) versus immediate cord clamping (ICC) at preterm birth and to examine its effects on initial blood pressure and other outcomes.
STUDY DESIGN:
A randomized controlled trial recruited 32 infants between 24 and 32 weeks. Immediately before delivery, mothers were randomized to ICC (cord clamped at 5 to 10 seconds) or DCC (30- to 45-second delay in cord clamping) groups.
RESULTS:
Intention-to-treat analyses revealed that the DCC group were more likely to have higher initial mean blood pressures (adjusted OR 3.4) and less likely to be discharged on oxygen (adjusted OR 8.6). DCC group infants had higher initial glucose levels (ICC=36 mg/dl, DCC=73.1 mg/dl; p=0.02).
CONCLUSION:
The research design is feasible. The immediate benefit of improved blood pressure was confirmed and other findings deserve consideration for further study.
AuthorsJudith S Mercer, Margaret M McGrath, Angelita Hensman, Helayne Silver, William Oh
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 23 Issue 6 Pg. 466-72 (Sep 2003) ISSN: 0743-8346 [Print] United States
PMID13679933 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Blood Pressure
  • Clinical Protocols
  • Constriction
  • Feasibility Studies
  • Female
  • Hematocrit
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Pilot Projects
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Research Design
  • Time Factors
  • Umbilical Cord

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: